Showing 21 - 40 of 1111 results
Advanced X-ray techniques have revealed new structural details about the specific arrangement of atoms in conjugated polymers, an important class of materials that are used in LEDs, organic solar cells, transistors, sensors and thermoelectric power devices.
ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.
ANSTO participates in nuclear medicine congress
ANSTO has been awarded a Community Recognition Statement from the NSW State Parliament for hosting an event to launch a new Dharawal language learning resource for preschool and primary-aged students.
ANSTO joined the Australian delegation at the 68th General Conference of the International Atomic Energy Agency (IAEA) last month in Vienna, participating in a number of insightful side-events and fruitful bilateral partnership meetings.
On behalf of Australia, ANSTO, the only nuclear reactor facility in Australia, supports the International Atomic Energy Agency (IAEA) to undertake its role in facilitating national, regional, and international efforts to enhance nuclear security, including measures to protect against nuclear terrorism.
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
Launch of the second phase of construction of the underground laboratory to detect dark matter.
Recently, a small delegation, including Yandruwandha Yawarrawarrka representatives from the remote outback settlement of Innamincka SA, travelled to ANSTO to deliver rare wooden Aboriginal archaeological artefacts for measurements to determine their age and origin.
ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.
Research on lunar meteorite and moon crater analogues coincides with Science Week.
ANSTO announces the recipients of the 2022 organisational awards
Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures